Literature DB >> 7175920

Mitogen-stimulated lymphocyte growth and chronic uraemia.

J H Gibbs, A J Robertson, R A Brown, R C Potts, J C Murdoch, W K Stewart, J S Beck.   

Abstract

Lymphocytes were isolated from venous blood by the Böyum method from 36 patients with chronic renal failure: the preparations were more frequently and more heavily contaminated with non-lymphoid cells than the equivalent preparations from normal controls. Volume spectroscopy measurements showed that, in the samples without gross contamination, lymphocytes from uraemic subjects react to mitogen stimulation with normal pre-S-phase cell-cycle kinetics. In other experiments, plasma from uraemic patients was shown to be more potent than serum in inhibiting the growth of mitogen-stimulated lymphocytes from normal subjects, both in the first G1-phase and in replicative growth. Thus humoral suppression appears to be more important than a cellular defect in explaining the depressed responses of uraemic blood to mitogen stimulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7175920

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  4 in total

1.  Some tetracycline drugs suppress mitogen-stimulated lymphocyte growth but others do not.

Authors:  R C Potts; A MacConnachie; R A Brown; J H Gibbs; A J Robertson; H A Hassan; J S Beck
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

2.  In vitro effects of doxycycline and tetracycline on mitogen stimulated lymphocyte growth.

Authors:  R C Potts; H A Hassan; R A Brown; A MacConnachie; J H Gibbs; A J Robertson; J S Beck
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

3.  T4 lymphopenia in patients with active pulmonary tuberculosis.

Authors:  J S Beck; R C Potts; T Kardjito; J M Grange
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

4.  Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV).

Authors:  R A Sharp; S M Morley; J S Beck; G E Urquhart
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.